Search

Search Constraints

You searched for: Author/Creator Pathil, Anita

Search Results

1. Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals: results from the German Hepatitis C-Registry. Issue 2 (February 2019)

2. Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs. (25th July 2019)

4. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Issue 6 (1st August 2018)

5. The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm. Issue 2 (4th July 2017)

6. Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort study. Issue 3 (25th June 2020)

7. Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma. Issue 11 (1st November 2016)

9. Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial. Issue 1 (January 2023)

10. Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real‐world setting. Issue 2 (1st March 2018)